A comparison of pediatric, adolescent, and adult testicular germ cell malignancy

Pediatric Blood and Cancer

Volumn 61, Issue 3, 2014, Pages 446-451

  Cost, Nicholas G ^a,b   Lubahn, Jessica D ^a   Adibi, Mehrad ^a   Romman, Adam ^a   Wickiser, Jonathan E ^a   Raj, Ganesh V ^a   Sagalowsky, Arthur I ^a   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent oncology; Germ cell malignancy; Pediatric oncology; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYONAL CARCINOMA; EVENT FREE SURVIVAL; FOLLOW UP; GERM CELL TUMOR; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INDUCTION CHEMOTHERAPY; INFANT; INTERNATIONAL COOPERATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEMINOMA; SURVIVAL RATE; TESTIS NONSEMINOMA CANCER; YOLK SAC TUMOR; YOUNG ADULT;

ADOLESCENT ONCOLOGY; GERM CELL MALIGNANCY; PEDIATRIC ONCOLOGY; TESTICULAR CANCER;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 84892492734     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24773     Document Type: Article

References (31)

1. Horner MJ, Ries LAG, Krapcho M, et al. SEER cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute (NCI); 2009.
2. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute (NCI); 2010.
3. Pohl HG, Shukla AR, Metcalf PD, et al. Prepubertal testis tumors: Actual prevalence rate of histological types. J Urol 2004; 172:2370-2372.
4. Taskinen S, Fagerholm R, Aronniemi J, et al. Testicular tumors in children and adolescents. J Pediatr Urol 2008; 4:134-137.
5. Haas RJ, Schmidt P, Gobel U, et al. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Klin Padiatr 1999; 211:300-304.
6. Schmidt P, Haas RJ, Gobel U, et al. Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children-An update. Klin Padiatr 2002; 214:167-172.
7. Gobel U, Calaminus G, Engert J, et al. Teratomas in infancy and childhood. Med Pediatr Oncol 1998; 31:8-15.
8. Shukla AR, Woodard C, Carr MC, et al. Experience with testis sparing surgery for testicular teratoma. J Urol 2004; 171:161-163.
9. Bussey KJ, Lawce HJ, Olson SB, et al. Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences-A Children's Cancer Group study. Genes Chromosomes Cancer 1999; 25:134-146.
10. Sokoloff MH, Joyce GF, Wise M. Testis cancer. J Urol 2007; 177:2030-2041.
11. Bleyer A. Adolescent and young adult (AYA) oncology: The first A. Pediatr Hematol Oncol 2007; 24:325-336.
12. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. New York: Springer-Verlag; 2010.
13. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594-603.
14. Subbiah V. Adolescent oncology: Who cares?-The new KID on the block. Support Care Cancer 2010; 18:771-773.
15. Powles TB, Bhardwa J, Shamash J, et al. The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 2005; 95:1197-1200.
16. Janssen-Heijnen ML, Gondos A, Bray F, et al. Clinical relevance of conditional survival of cancer patients in Europe: Age-specific analyses of 13 cancers. J Clin Oncol 2010; 28:2520-2528.
17. Smith MA, Gurney JG, Ries LAG. " Cancer among adolescents 15-19 years old" in the SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute (NCI); 2008.
18. Veneroni L, Mariani L, Lo Vullo S, et al. Symptom interval in pediatric patients with solid tumors: Adolescents are at greater risk of late diagnosis. Pediatr Blood Cancer 2013; 60:605-610.
19. Festa RS, Tamaroff MH, Chasalow F, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 1992; 120:807-811.
20. Tebbi CK, Cummings KM, Zevon MA, et al. Compliance of pediatric and adolescent cancer patients. Cancer 1986; 58:1179-1184.
21. Kondryn HJ, Edmondson CL, Hill J, et al. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol 2011; 12:100-108.
22. Maule M, Malavassi JL, Richiardi L. Age at puberty and risk of testicular cancer: A meta-analysis. Int J Androl 2012; 35:828-834.
23. Jorgensen A, Nielsen JE, Almstrup K, et al. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ. J Pathol 2013; 229:588-598.
24. Hayes-Lattin B, Nichols CR. Testicular cancer: A prototypic tumor of young adults. Semin Oncol 2009; 36:432-438.
25. Schlatter M, Rescorla F, Giller R, et al. Excellent outcome in patients with stage I germ cell tumors of the testes: A study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg 2003; 38:319-324, discussion 319-324.
26. NCCN. Clinical practice guidelines in oncology: Testicular cancer. Washington, PA: National Comprehensive Cancer Network; 2012; v.1.2012.
27. Rogers PC, Olson TA, Cullen JW, et al. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 2004; 22:3563-3569.
28. Shaikh F, Nathan PC, Hale J, et al. Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials. Pediatr Blood Cancer 2013; 60:587-592.
29. NCCN. Clinical practice guidelines in oncology: Testicular cancer. Washington, PA: National Comprehensive Cancer Network; 2010; v.1.2010.
30. Rescorla FJ. Pediatric germ cell tumors. Semin Surg Oncol 1999; 16:144-158.
31. Sagalowsky AI. Treatment options for patients with stage I nonseminomatous testis cancer: It's all good. Eur Urol 2011; 59:563-565.